Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-23-005290
Filing Date
2023-03-17
Accepted
2023-03-17 21:31:08
Documents
1
Period of Report
2023-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 9569
  Complete submission text file 0001567619-23-005290.txt   11229
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA BIOSCIENCES, INC. 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Malecek Michael J (Reporting) CIK: 0001779336 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35676 | Film No.: 23744759